Self-inactivating retroviral vectors with improved RNA processing

被引:68
作者
Kraunus, J
Schaumann, DHS
Meyer, J
Modlich, U
Fehse, B
Brandenburg, G
von Laer, D
Klump, H
Schambach, A
Bohne, J
Baum, C
机构
[1] Hannover Med Sch, Dept Hematol Hemostaseol & Oncol, D-30625 Hannover, Germany
[2] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Cell & Virus Genet, D-2000 Hamburg, Germany
[3] Univ Hosp Eppendorf, Hamburg, Germany
[4] Georg Speyer Haus, Frankfurt, Germany
[5] Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH USA
关键词
mouse leukemia virus; vector safety; hematopoiesis;
D O I
10.1038/sj.gt.3302309
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three RNA features have been identified that elevate retroviral transgene expression: an intron in the 5 0 untranslated region (5' UTR), the absence of aberrant translational start codons and the presence of the post-transcriptional regulatory element (PRE) of the woodchuck hepatitis virus in the 3 'UTR. To include such elements into self-inactivating ( SIN) vectors with potentially improved safety, we excised the strong retroviral promoter from the U3 region of the 3' long terminal repeat (LTR) and inserted it either downstream or upstream of the retroviral RNA packaging signal (Psi). The latter concept is new and allows the use of an intron in the 5' UTR, taking advantage of retroviral splice sites surrounding Psi. Three LTR and four SIN vectors were compared to address the impact of RNA elements on titer, splice regulation and transgene expression. Although titers of SIN vectors were about 20-fold lower than those of their LTR counterparts, inclusion of the PRE allowed production of more than 106 infectious units per ml without further vector optimizations. In comparison with state-of-the-art LTR vectors, the intron-containing SIN vectors showed greatly improved splicing. With regard to transgene expression, the intron-containing SIN vectors largely matched or even exceeded the LTR counterparts in all cell types investigated ( embryonic carcinoma cells, fibroblasts, primary T cells and hematopoietic progenitor cells).
引用
收藏
页码:1568 / 1578
页数:11
相关论文
共 49 条
[1]  
Ailles LE, 2002, CURR TOP MICROBIOL, V261, P31
[2]   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning [J].
Aiuti, A ;
Slavin, S ;
Aker, M ;
Ficara, F ;
Deola, S ;
Mortellaro, A ;
Morecki, S ;
Andolfi, G ;
Tabucchi, A ;
Carlucci, F ;
Marinello, E ;
Cattaneo, F ;
Vai, S ;
Servida, P ;
Miniero, R ;
Roncarolo, MG ;
Bordignon, C .
SCIENCE, 2002, 296 (5577) :2410-2413
[3]   RTCGD: retroviral tagged cancer gene database [J].
Akagi, K ;
Suzuki, T ;
Stephens, RM ;
Jenkins, NA ;
Copeland, NG .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D523-D527
[4]   Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements [J].
Ayuk, FA ;
Li, Z ;
Kühlcke, K ;
Lindemann, C ;
Schade, UM ;
Eckert, HG ;
Zander, AR ;
Fehse, B .
GENE THERAPY, 1999, 6 (10) :1788-1792
[5]  
Baum C, 1999, CURR OPIN MOL THER, V1, P605
[6]   The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF [J].
Baum, C ;
Itoh, K ;
Meyer, J ;
Laker, C ;
Ito, Y ;
Ostertag, W .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6323-6331
[7]   Side effects of retroviral gene transfer into hematopoietic stem cells [J].
Baum, C ;
Düllmann, J ;
Li, ZX ;
Fehse, B ;
Meyer, J ;
Williams, DA ;
von Kalle, C .
BLOOD, 2003, 101 (06) :2099-2114
[8]   NOVEL RETROVIRAL VECTORS FOR EFFICIENT EXPRESSION OF THE MULTIDRUG-RESISTANCE (MDR-1) GENE IN EARLY HEMATOPOIETIC-CELLS [J].
BAUM, C ;
HEGEWISCHBECKER, S ;
ECKERT, HG ;
STOCKING, C ;
OSTERTAG, W .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7541-7547
[9]   MULTIPLE MODIFICATIONS IN CIS-ELEMENTS OF THE LONG TERMINAL REPEAT OF RETROVIRAL VECTORS LEAD TO INCREASED EXPRESSION AND DECREASED DNA METHYLATION IN EMBRYONIC CARCINOMA-CELLS [J].
CHALLITA, PM ;
SKELTON, D ;
ELKHOUEIRY, A ;
YU, XJ ;
WEINBERG, K ;
KOHN, DB .
JOURNAL OF VIROLOGY, 1995, 69 (02) :748-755
[10]   Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptides [J].
Egelhofer, M ;
Brandenburg, G ;
Martinius, H ;
Schult-Dietrich, P ;
Melikyan, G ;
Kunert, R ;
Baum, C ;
Choi, I ;
Alexandrov, A ;
von Laer, D .
JOURNAL OF VIROLOGY, 2004, 78 (02) :568-575